Keith Henry - Concepedia

Author

Keith Henry

Also Known As

Carlos del Rio, Charles B Hicks, Dennis Cunniff, Herbert Cantrill, K HENRY, K Henry, K. HENRY, K. Henry, KEITH HENRY, Kehli Henry

487

Publications

11.2K

Citations

H-Index

130

Concepts

All Affiliations

Hennepin County Medical Center University of Minnesota Washington University in St. Louis Centers for Disease Control and Prevention University of California, San Francisco

About

Keith Henry is an author at Hennepin County Medical Center specializing in medicine, hiv, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	31	42	4.1K
2	Health Sciences	5	5	200
3	Engineering	3	3	743
4	Management	1	1	16
5	Natural Sciences	1	1	154

Keith Henry

109

Publications

9.8K

Citations

H-Index

Page 1

	Year	Citations
Enfuvirtide, an HIV-1 Fusion Inhibitor, for Drug-Resistant HIV Infection in North and South America Jacob Lalezari, Keith Henry, Mary O’Hearn, New England Journal of Medicine	2003	909
Kinetics of Response in Lymphoid Tissues to Antiretroviral Therapy of HIV-1 Infection Winston Cavert, Daan W. Notermans, Katherine Staskus, Science	1997	629
Quantitative Image Analysis of HIV-1 Infection in Lymphoid Tissue Ashley T. Haase, Keith Henry, Mary Zupancic, Science EngineeringTissue ReservoirsImmunologyViral DynamicPathology	1996	605
Co-formulated elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate versus ritonavir-boosted atazanavir plus co-formulated emtricitabine and tenofovir disoproxil fumarate for initial treatment of HIV-1 infection: a randomised, double-blind, phase 3, non-inferiority trial Edwin DeJesus, Jürgen K. Rockstroh, Keith Henry, The Lancet Hiv/aids CounsellingTreatment And PreventionMedicineAntiviral Drug DevelopmentClinical Trials	2012	346
Primary Infection with Zidovudine-Resistant Human Immunodeficiency Virus Type 1 Alejo Erice, Douglas L. Mayers, David G. Strike, New England Journal of Medicine Primary ImmunodeficiencyVirus ResistantHuman RetrovirusPathogenesisImmunology	1993	244
Once-daily dolutegravir versus darunavir plus ritonavir for treatment-naive adults with HIV-1 infection (FLAMINGO): 96 week results from a randomised, open-label, phase 3b study Jean‐Michel Molina, Bonaventura Clotet, Jan van Lunzen, The Lancet HIV Dolutegravir Versus DarunavirTreatment And PreventionAntiviral Drug DevelopmentClinical TrialsAntiviral Therapy	2015	220
Kinetics of CD4+ T cell repopulation of lymphoid tissues after treatment of HIV-1 infection Zhi‐Qiang Zhang, Daan W. Notermans, Gerald Sedgewick, Proceedings of the National Academy of Sciences ImmunologyViral DynamicImmune SystemImmunotherapyTotal Cd4+ T	1998	217
Use of Intravitreal Ganciclovir (Dihydroxy Propoxymethyl Guanine) for Cytomegalovirus Retinitis in a Patient With AIDS Keith Henry, Herbert L. Cantrill, Courtney V. Fletcher, American Journal of Ophthalmology Viral PersistenceDihydroxy Propoxymethyl GuanineImmunologyAntiviral Drug DevelopmentAntiviral Therapy	1987	196
The Control of HIV After Antiretroviral Medication Pause (CHAMP) Study: Posttreatment Controllers Identified From 14 Clinical Studies Golnaz Namazi, Jesse Fajnzylber, Evgenia Aga, The Journal of Infectious Diseases	2018	192
Treatment of Cytomegalovirus Retinitis with Intravitreal Ganciclovir Herbert L. Cantrill, Keith Henry, N. Holly Melroe, Ophthalmology Viral PersistenceAntiviral TherapyVirologyCytomegalovirus RetinitisAntiviral Drug	1989	185

Page 1